Independent Medical Education Request for Proposals - MOGAD
Genentech funds independent medical education to improve clinician knowledge and management of Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) through innovative, evidence-based programs.
Funder: Genentech
Due Dates: July 24, 2026: Full grant proposal submission deadline
Funding Amounts: Up to $200,000 per award; single-year support; total number of awards not specified.
Summary: Supports independent medical education initiatives to advance healthcare professional knowledge and management of Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD).
Description
Genentech invites proposals for independent, certified medical education projects focused on Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD). The goal is to fund innovative educational programs that address evidence-based gaps in the diagnosis and management of MOGAD among U.S. healthcare professionals. Supported activities should improve patient care by enhancing the knowledge, competence, and performance of clinicians, particularly in differentiating MOGAD from overlapping demyelinating conditions and updating them on new, disease-specific management strategies.
Target audiences include neuroimmunologists, general neurologists, emergency medicine physicians, primary care providers, and ophthalmologists. Educational initiatives must be U.S.-based and designed for healthcare professionals.
